Sunshine Biopharma (SBFM) EBITDA Margin (2015 - 2026)
Sunshine Biopharma's (SBFM) quarterly EBITDA Margin came in at 17.25% in Q1 2026, down 270.0% YoY from 10.15% in Q1 2025, and up 17.33% on a QoQ basis from 20.87% in Q4 2025.
Sunshine Biopharma (SBFM) EBITDA Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of EBITDA Margin data on file, last reported at 17.25% in Q1 2026.
- Quarterly EBITDA Margin fell 270.0% year-over-year to 17.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.83% (down 207.0% YoY) and the FY2025 annual result came in at 17.15%, down 49.0% from the prior year.
- EBITDA Margin grew to 17.25% in Q1 2026, from 20.87% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 11.54% in Q3 2025 to a low of 1293.58% in Q3 2022.
- A 5-year average of 210.77% and a median of 18.23% in 2023 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 218701 bps in 2022, down 30847 bps in 2022.
- Tracing SBFM's EBITDA Margin over 5 years: stood at 593.01% in 2022, then jumped by 97 bps to 15.46% in 2023, then tumbled by 37 bps to 21.24% in 2024, then gained by 2 bps to 20.87% in 2025, then gained by 17 bps to 17.25% in 2026.
- The last three EBITDA Margin figures came in at 17.25% (Q1 2026), 20.87% (Q4 2025), and 11.54% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | -17.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.41% |
| Mar 31, 2026 | -17.25% |
| Dec 31, 2025 | -20.87% |
| Sep 30, 2025 | -11.54% |
| Jun 30, 2025 | -21.83% |
| Mar 31, 2025 | -14.56% |
| Dec 31, 2024 | -21.24% |
| Sep 30, 2024 | -13.12% |
| Jun 30, 2024 | -13.63% |
| Mar 31, 2024 | -17.91% |
| Dec 31, 2023 | -15.46% |
| Sep 30, 2023 | -13.08% |
| Jun 30, 2023 | -18.23% |
| Mar 31, 2023 | -37.37% |
| Dec 31, 2022 | -593.01% |
| Sep 30, 2022 | -1,293.58% |
| Jun 30, 2022 | -462.92% |
| Mar 31, 2022 | -997.48% |
| Dec 31, 2021 | -328.52% |
| Sep 30, 2021 | -985.11% |